๐ฐ News12 March 2026ยท2 min readยท
MHRA Approves Deuruxolitinib (Leqselvi) for Severe Alopecia Areata
Source: govuk-visas
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved deuruxolitinib, marketed as Leqselvi, for the treatment of severe alopecia areata in adults. The approval was announced on 12 March 2026. The MHRA confirmed it will continue to monitor the safety and effectiveness of the drug under close review.
๐ฌ
Join the Discussion
Discuss in the News thread
